Kyle Tretina, PhD’s Post

Revolutionizing Target Discovery and Precision Medicine with Cell-Based Phage Display! Unlocking the potential of novel therapeutics and diagnostics demands precise targeting of disease-specific molecules. Cell-based phage display offers a powerful solution, enabling the identification of high-affinity peptides that bind to targets in their natural cellular context. This innovative technology streamlines drug discovery, diagnostics development, and fundamental research across various therapeutic areas. Read our latest blog post to learn how Biosynth is leveraging cell-based phage display to accelerate the development of targeted therapies and precision medicine tools. https://lnkd.in/ese4CMfW #phageDisplay #biotechnology #drugdiscovery #diagnostics #precisionmedicine #innovation #Biosynth

Preclinical study showed that microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin: https://lnkd.in/dPD_RUMV  #Huntington #Microglia #PharmacolRes #openaccess #Research 

🔬 How do researchers ensure #nanobody precision and scalability? Developing nanobodies tailored for specific applications is complex and requires access to diverse animal sources and robust discovery platforms. Researchers face challenges like ensuring nanobody stability, improving binding affinity, and maintaining rapid development timelines. 📊 Challenges in nanobody discovery: • Diverse sourcing: Developing robust libraries from camelid and shark nanobodies is critical. • Streamlined workflows: Target preparation, antibody screening, and optimization must be seamless. • Faster timelines: Reducing the time from discovery to application accelerates research. 🔍 How discovery services help: A comprehensive platform can streamline nanobody sourcing, development, and delivery, providing researchers with the right tools for diagnostics and therapeutics. 📖 Learn more about nanobody discovery here: https://lnkd.in/gkkpyWbU 💬 Question for You: How would access to high-quality nanobody libraries accelerate your research? #NanobodyDiscovery #BiotechSolutions #AdvancedResearch #PrecisionMedicine

The clinical development pipeline growth and investment in modalities such as cell and gene therapy, mRNA, radiopharmaceuticals, and antibody-drug conjugates (ADCs) have nearly doubled in the last five years. This growth, alongside scientific advances in data-driven tools, presents new possibilities for biotech drug development. While these advancements bring tremendous opportunities, they also come with complexity. Get the latest insights from our commercial strategists at Health Advances (A Parexel Company). Stay ahead of the curve in the dynamic landscape of clinical development. #ClinicalDevelopment #BiotechInvestment #ScientificAdvances #ParexelBiotech

Nature's blueprints: advancing drug development with biomimetic culture Explore: The art of creating models that bridge the gap between in vitro and in vivo, enhancing biological relevance. Practical considerations of crafting and sustaining these cultures. The impact of biomimetic culture on disease modeling, drug development, and preclinical evaluation. Click below to access.

The clinical development pipeline growth and investment in modalities such as cell and gene therapy, mRNA, radiopharmaceuticals, and antibody-drug conjugates (ADCs) have nearly doubled in the last five years. This growth, alongside scientific advances in data-driven tools, presents new possibilities for biotech drug development. While these advancements bring tremendous opportunities, they also come with complexity. Get the latest insights from our commercial strategists at Health Advances (A Parexel Company). Stay ahead of the curve in the dynamic landscape of clinical development. #ClinicalDevelopment #BiotechInvestment #ScientificAdvances #ParexelBiotech

The clinical development pipeline growth and investment in modalities such as cell and gene therapy, mRNA, radiopharmaceuticals, and antibody-drug conjugates (ADCs) have nearly doubled in the last five years. This growth, alongside scientific advances in data-driven tools, presents new possibilities for biotech drug development. While these advancements bring tremendous opportunities, they also come with complexity. Get the latest insights from our commercial strategists at Health Advances (A Parexel Company). Stay ahead of the curve in the dynamic landscape of clinical development. #ClinicalDevelopment #BiotechInvestment #ScientificAdvances #ParexelBiotech

The clinical development pipeline growth and investment in modalities such as cell and gene therapy, mRNA, radiopharmaceuticals, and antibody-drug conjugates (ADCs) have nearly doubled in the last five years. This growth, alongside scientific advances in data-driven tools, presents new possibilities for biotech drug development. While these advancements bring tremendous opportunities, they also come with complexity. Get the latest insights from our commercial strategists at Health Advances (A Parexel Company). Stay ahead of the curve in the dynamic landscape of clinical development. #ClinicalDevelopment #BiotechInvestment #ScientificAdvances #ParexelBiotech

The clinical development pipeline growth and investment in modalities such as cell and gene therapy, mRNA, radiopharmaceuticals, and antibody-drug conjugates (ADCs) have nearly doubled in the last five years. This growth, alongside scientific advances in data-driven tools, presents new possibilities for biotech drug development. While these advancements bring tremendous opportunities, they also come with complexity. Get the latest insights from our commercial strategists at Health Advances (A Parexel Company). Stay ahead of the curve in the dynamic landscape of clinical development. #ClinicalDevelopment #BiotechInvestment #ScientificAdvances #ParexelBiotech

🚀 We’re proud to share our latest article on the critical role of preclinical imaging in drug development. Discover how HawkCell's advanced technologies tackle complex challenges and set new standards in the preclinical research field. 📖 Read the article here: https://lnkd.in/dNgxstTG #Preclinical #Imaging #Research #MRI #HawkCell